UK markets close in 6 hours 20 minutes

Aveanna Healthcare Holdings Inc. (AVAH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.2700-0.0200 (-0.87%)
At close: 04:00PM EDT
2.2700 0.00 (0.00%)
After hours: 04:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.2900
Open2.2400
Bid2.2100 x 100
Ask2.3300 x 100
Day's range2.2200 - 2.3350
52-week range0.8500 - 3.0000
Volume38,231
Avg. volume94,009
Market cap436.7M
Beta (5Y monthly)2.04
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Aveanna Announces First Quarter 2024 Earnings Release Date and Conference Call

    ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 9, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be ac

  • GlobeNewswire

    Aveanna Healthcare Holdings Announces Appointment of Chief Legal Officer and Secretary

    ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer and Secretary, effective April 29, 2024. “I am pleased to announce the appointment of Jerry to the Chief Legal Officer and Secretary role. Jerry has a strong background in corporate law and a wealth of hea

  • GlobeNewswire

    Aveanna Healthcare Holdings Announces Fourth Quarter 2023 Financial Results and 2024 Outlook

    Fourth Quarter Revenue was $478.8 million, a 6.1% increase over the prior year Gross margin increased 15.3% to $148.4 million, compared to Q4 2022 Fourth Quarter Net loss was $25.7 million, compared to net loss of $237.8 million in the comparable prior year period Adjusted EBITDA was $38.7 million, a 30.4% increase as compared to the prior year quarter Expect Full Year 2024 Revenue between $1,960 million and $1,980 million and Adjusted EBITDA between $146 million and $150 million ATLANTA, March